- Home
- LXFR vs ENGN Comparison
LXFR vs ENGN Comparison
Compare LXFR & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXFR
- ENGN
- Stock Information
- Founded
- LXFR 1898
- ENGN 1999
- Country
- LXFR United States
- ENGN Canada
- Employees
- LXFR N/A
- ENGN N/A
- Industry
- LXFR Major Chemicals
- ENGN
- Sector
- LXFR Industrials
- ENGN
- Exchange
- LXFR Nasdaq
- ENGN Nasdaq
- Market Cap
- LXFR 380.9M
- ENGN 317.6M
- IPO Year
- LXFR 2012
- ENGN N/A
- Fundamental
- Price
- LXFR $14.17
- ENGN $6.29
- Analyst Decision
- LXFR
- ENGN Buy
- Analyst Count
- LXFR 0
- ENGN 10
- Target Price
- LXFR N/A
- ENGN $26.40
- AVG Volume (30 Days)
- LXFR 118.2K
- ENGN 179.6K
- Earning Date
- LXFR 02-25-2025
- ENGN 03-10-2025
- Dividend Yield
- LXFR 3.59%
- ENGN N/A
- EPS Growth
- LXFR 57.96
- ENGN N/A
- EPS
- LXFR 0.34
- ENGN N/A
- Revenue
- LXFR $384,400,000.00
- ENGN N/A
- Revenue This Year
- LXFR N/A
- ENGN N/A
- Revenue Next Year
- LXFR $3.44
- ENGN N/A
- P/E Ratio
- LXFR $45.29
- ENGN N/A
- Revenue Growth
- LXFR N/A
- ENGN N/A
- 52 Week Low
- LXFR $7.61
- ENGN $4.42
- 52 Week High
- LXFR $15.64
- ENGN $18.40
- Technical
- Relative Strength Index (RSI)
- LXFR 51.57
- ENGN 44.90
- Support Level
- LXFR $14.11
- ENGN $5.51
- Resistance Level
- LXFR $14.71
- ENGN $7.00
- Average True Range (ATR)
- LXFR 0.41
- ENGN 0.74
- MACD
- LXFR -0.01
- ENGN -0.01
- Stochastic Oscillator
- LXFR 48.03
- ENGN 43.43
About LXFR Luxfer Holdings PLC
Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.